Declan Gaynor

发表

Non-linear optical measurement of Iron(III) Tris(pyridinehydroxamate) complexes

F. Henari, D. Griffith, C. Marmion, 2012 .

Exploring changes in levels and patterns of physical activity in undergraduate medical and nursing students during the COVID-19 pandemic

A. Al-Hindawi, Nitya Kumar, Declan Gaynor, 2022, Frontiers in Public Health.

Metal complexes of cyclic hydroxamates. Synthesis and crystal structures of 3-hydroxy-2-methyl-3H-quinazolin-4-one (ChaH) and of its Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) complexes

H. Müller‐Bunz, L. Parthasarathi, Ahmed Alagha, 2011 .

High nuclearity Ni(II) cages from hydroxamate ligands

M. Singh, G. Rajaraman, E. Brechin, 2014 .

Synthesis and structure of a heptanuclear nickel(II) complex uniquely exhibiting four distinct binding modes, two of which are novel, for a hydroxamate ligand.

W. Haase, K. Nolan, Z. Starikova, 2002, Chemical communications.

Copper(II) complexes of isomeric aminophenylhydroxamic acids. A novel 'clam-like' dimeric metallacrown and polymeric helical structure containing interlinked unique copper(II) sites

W. Haase, K. Nolan, Z. Starikova, 2001 .

Progressive Decoration of Pentanuclear Cu(II) 12-Metallacrown- 4 Nodes Towards Targeted 1- and 2D Extended Networks‡**

E. Brechin, L. Jones, Stephanie M. Taylor, 2013 .

The prevalence of metal-based drugs as therapeutic or diagnostic agents: beyond platinum.

D. Griffith, Declan Gaynor, 2012, Dalton transactions.

fac-Tris(4-aminobenzohydroxamato)iron(III) ethanol solvate

H. Müller‐Bunz, L. Parthasarathi, Ahmed Alagha, 2010, Acta Crystallographica Section E.